Inga Hofmann, M.D.
Co-investigator Emery Bresnick, Ph.D.

University of Wisconsin-Madison

Discovery Research Grant 2017

Prognostic Markers and Therapeutic Targets in...

Harry L. Grimes, Ph.D.

Cincinnati Children’s Hospital Medical Center

Discovery Research Grant 2017

Mechanisms of ineffective hematopoiesis underlying...

Saar I. Gill, M.D., Ph.D.

University of Pennsylvania

Discovery Research Grant 2017

Targeting the MDS stem cell using anti-IL1RAP...

Todd A. Fehniger, M.D., Ph.D.

Washington University

Discovery Research Grant 2017

Harnessing NK cells for the therapy of MDS.

Benjamin Ebert, M.D., Ph.D.

Brigham & Women’s Hospital

Discovery Research Grant 2017

PPM1D is a promising new therapeutic target for MDS

Teresa V. Bowman, Ph.D.

Albert Einstein College of Medicine

Discovery Research Grant 2017

Finding new therapies for MDS through chemical...

Emery Bresnick, Ph.D.
Co-investigator Inga Hofman, M.D.

University of Wisconsin-Madison

Discovery Research Grant 2017

Prognostic Markers and Therapeutic Targets in...

R. Coleman Lindsley, M.D., Ph.D.

Dana-Farber Cancer Institute

Discovery Research Grant 2016

The context-dependent role of BCOR mutations in MDS ...

Stephanie Halene, M.D., Ph.D.

Yale University School of Medicine

Discovery Research Grant 2016

Study of MDS Biology and Response to Targeted ...

Craig T. Jordan, Ph.D.

University of Colorado Denver

Translational Research Grant 2016

Adoptive CD123 CAR T-cell therapy for the treatment ...

Elli Papaemmanuil, Ph.D.

Memorial Sloan-Kettering Cancer Center

Discovery Research Grant 2016

Biological Consequences of SF3B1 mutations in MDS

Thomas A. Look, M.D.

Dana-Farber Cancer Institute

Discovery Research Grant 2016

Identification of drugs that are in Phase I/II ...